Why cancer drug Keytruda costs so much—and who really pays the price?
A life-saving cancer drug hailed as a breakthrough in modern medicine has become a symbol of a deeply unequal global health care system. A yearlong investigation by the International Consortium of Investigative Journalists (ICIJ) has revealed how Merck & Co. has maintained sky-high prices for its blockbuster drug Keytruda, effectively locking out patients worldwide while […]